National Center for Health Research Comment on the Centers for Disease Control and Prevention’s (CDC) proposed new Recommendations for Hepatitis C Testing Among Perinatally Exposed Infants and Children

January 27, 2023: Hepatitis C infections have dramatically increased among pregnant women, which exposes babies during birth. National Center for Health Research supports CDC’s recommendations for HCV testing of all infants and children born to pregnant mothers with confirmed or probable HCV.

Read More »

NCHR’s Comment on the Consumer Product Safety Commission’s Proposed Ruling of Safety Standards for Adult Portable Bed Rails

January 9, 2023: NCHR strongly agrees with CPSC’s proposed ruling that APBR has an “unreasonable risk of injury and death associated with entrapment hazards” and enthusiastically supports CPSC’s plan to make the voluntary safety standards mandatory, include new requirements for testing and labeling, and consider banning the products if the new standards do not substantially improve their safety. It is important to consider alternatives to APBR’s if it becomes necessary to ban them, and alternatives can be bed trapezes, adjustable beds, nonslip mattress pads, and bed exit alarms.

Read More »

NCHR urges FDA to require more diversity in trials to improve accuracy of pulse ox devices

December 2, 2022: NCHR testified at an FDA meeting that there is strong evidence that commonly-used pulse oximeters are less reliable for patients with pigmented skin. The FDA’s current guidelines do not require product labeling to address the impact of skin pigmentation on pulse oximetry. While labeling is important to alert users to possible inaccuracies, it does not diminish the importance of developing devices that are effective for everyone.

Read More »